AGH ALLEGHENY GENERAL HOSPITAL
Histological evaluation of the presence and degree of dysplasia in patients with Barrett's esophagus (BE) is often subjective and challenging. We evaluated a panel of molecular markers to analyze the degree of molecular change in conjunction with histologic findings. Biopsy specimens from 20 patients with a diagnosis of Barrett's (intestinal metaplasia) with dysplasia (n=19), and intestinal metaplasia without dysplasia (n=1) were examined. Multiple microdissection targets (n=57) from formalin-fixed, paraffin-embedded slides were tested for loss of heterozygosity (LOH) mutations and/or microsatellite instability in a panel of 17 microsatellite markers using PCR. The presence/absence of LOH and the proportion of cells affected by LOH were quantitatively determined, with high clonality mutations representing >75% of cells, and low clonality representing 50-75%. We estimated mutation load using values for low and high clonality mutations and microsatellite instability. All targets in this series showed mutations, including those without dysplasia. Microdissection targets with histologic high-grade dysplasia (HGD, range 2.0-6.0, average 3.3) had higher mutation load than low-grade dysplasia (LGD, range 1.50-4.5, average 2.4). Targets with carcinoma in situ (CIS) showed significantly higher Mutational load (ML), i.e. number and clonality of mutation, increased with increasingly severe histologic classification (Corr. Coef., (ρ), =0.83; p<0.0001) (Fig. 2) . ML in non-dysplastic microdissection targets (i.e., only IM present) had a maximum ML of less than 2 ( Table 2 ). All targets with HGD or HGD with CIS showed ML of greater than or equal to 2 ( Table 2 ). All microdissection targets in this series with dysplasia showed LOH and/or MSI. No non-dysplastic targets exhibited MSI. In all targets with mutations 60% (32/53) exhibited LOH only, 38% (20/53) exhibited LOH and MSI, and 2% (1/53) exhibited MSI only. Table 1 . Frequency of mutated DNA at each loci according to histological classification of targets tested. Red boxes indicate at least 25% of targets were mutated within each histological classification. Figure 1 . Specimens were microdissected into targets for mutational load analysis. classification. this study, we aimed to evaluate the mutational load in intestinal metaplasia and low and high-grade dysplasia as an objective means to better classify the progression of disease in Barrett's esophagus.
INTRODUCTION
Genomic instability, as represented by mutational load (ML), increases with increasingly severe grade of disease. Cells with the same histological appearance have distinct levels of genomic instability, which may help to explain why some undergo disease progression and others do not. Examining mutation loads (ML) may provide an additional dimension to the observed histology in BE patients, potentially helping to define subsets of patients with greater risk for further disease progression.
METHODS
We reviewed FFPE biopsies from 20 patients. Slides were microdissected based on histological features into 57 targets (Fig. 1) . Targets were genotyped for loss of heterozygosity (LOH) using a panel of 17 markers targeting 10 regions with known tumor suppressor genes (Table 1) . LOH Mutations were quantitatively detected with high clonality representing >75% of cells/DNA affected and low clonality representing 50%-75% of cells affected. The presence of microsatellite instability at loci examined for LOH was also reported. We established a measure of mutational load (ML) that incorporated both the number and the clonality of mutations; high clonality was weighted at twice that of low clonality, with MSI weighted between low and high. 
